Erythema multiforme (EM) is a rare skin condition that is characterized by an itchy rash that appears on the skin in the form of red patches, bumps, or blisters. It is usually caused by an allergic reaction to a medication or infection, but can also be caused by an autoimmune disorder. The condition can be mild or severe, and it can affect people of any age. While the rash can be painful and uncomfortable, it is usually not serious and can be treated with over-the-counter medications or topical creams. In this article, we will provide a visual guide to erythema multiforme, including what it looks like, the symptoms associated with it, and the treatment options available.
Erythema multiforme typically appears as red patches, bumps, or blisters on the skin. The rash can appear anywhere on the body, but is most commonly found on the hands, feet, and face. The rash can range in size from a few millimeters to several centimeters in diameter. It is usually symmetrical, meaning that it appears on both sides of the body. The rash is usually itchy and can be painful or tender to the touch. The rash can also have a “target” or “bull’s-eye” appearance, with a central red area surrounded by a ring of paler red. This is known as the “iris” pattern and is a characteristic of erythema multiforme. In some cases, the rash may also have a purplish or bluish hue.
In addition to the rash, erythema multiforme can also cause other symptoms, including fever, chills, sore throat, and fatigue. In some cases, the rash may be accompanied by eye irritation, such as redness, swelling, and pain. It is important to note that erythema multiforme is not contagious and cannot be spread from person to person.
Erythema multiforme is usually caused by an allergic reaction to a medication or infection. Common triggers include antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants. In some cases, the condition can be caused by an autoimmune disorder, such as lupus or Sjogren’s syndrome.
Erythema multiforme is usually diagnosed based on the appearance of the rash. Your doctor may also take a skin sample (biopsy) to confirm the diagnosis. In some cases, blood tests may be used to rule out other conditions that may be causing the rash.
The treatment of erythema multiforme depends on the severity of the condition. Mild cases may be treated with over-the-counter medications, such as antihistamines, or topical creams. In more severe cases, your doctor may prescribe oral steroids or other medications to reduce inflammation and itching.
Erythema multiforme is a rare skin condition that is characterized by an itchy rash that appears on the skin in the form of red patches, bumps, or blisters. It is usually caused by an allergic reaction to a medication or infection, but can also be caused by an autoimmune disorder. While the rash can be painful and uncomfortable, it is usually not serious and can be treated with over-the-counter medications or topical creams. This article provided a visual guide to erythema multiforme, including what it looks like, the symptoms associated with it, and the treatment options available.
1.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer
2.
Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib
3.
In prostate cancer survivorship, sleep disturbances are underappreciated.
4.
Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer
5.
a cutting-edge cancer diagnostic tool.
1.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
2.
Community Survivorship Networks for Long-Term Cancer Wellness
3.
Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management
4.
Targeted Therapies for Breast Cancer: What’s New?
5.
Integrated Insights in Hematology and Quality Improvement
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Hands-on Workshop: Hematology
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation